Keros, after halting 2 cohorts over fluid buildups around heart, pulls plug on hypertension trial
Fecha de publicación:
15/01/2025
Fuente: FierceBiotech
A month after halting dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial hypertension drug, Keros Therapeutics has now pulled the plug on the study entirely.